About this approach
LITT places a thin laser probe into a target and uses heat, commonly monitored with MRI temperature imaging, to destroy planned tissue. In oncology it is most often considered for selected primary or metastatic brain tumors, radiation necrosis, or lesions that are difficult to reach with open surgery.
Where it fits: Minimally invasive laser ablation for selected brain lesions
Where this treatment is used
Use of LITT varies by diagnosis and center. The team should distinguish an FDA-cleared device from proof that LITT is the best cancer treatment for a particular patient.
Procedure and practical considerations
Risks include bleeding, infection, swelling, seizures, neurologic injury, incomplete ablation, and the need for further surgery or treatment. Heating near critical brain structures may limit the treatment area. MRI compatibility and recovery planning are important.
Clinics reporting this approach
These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.
Sources
Source information checked: 2026-10-07. The links below identify the public and clinic-provided materials used for this page.
Compiled by: Cancer Clinic Finder Editorial Team
- FDA 510(k): NeuroBlate/System laser ablation documentation ↗Checked 2026-10-07
- NCI: Lasers in Cancer Treatment ↗Checked 2026-10-07
How Cancer Clinic Finder compiles information · Suggest a factual correction
